Medindia LOGIN REGISTER
Medindia
Advertisement

Pharmaceutical and Health Care Experts to Detail Cost-Cutting Capabilities of Secure Digital Signatures

Tuesday, December 16, 2008 General News
Advertisement
LOS GATOS, Calif., Dec. 16 TriCipher will host aninformative Webinar detailing the cost cutting capabilities of digitalsignatures for the pharmaceutical and health care industries and strategiesfor securing digital signatures as more business processes transition online.The one hour webinar on December 16th brings together executives from SAFE-BioPharma Association and Pfizer who will discuss how digital signatures havebenefited and streamlined research processes.
Advertisement

"Digital signatures represent the 'last mile' in moving business processesonline for the pharmaceutical and health care industries," said Jon Brody,vice president of marketing at TriCipher. "Through the work of industryassociations like SAFE-BioPharma and enabling technology companies likeTriCipher, it's now possible to bridge that gap."
Advertisement

The webinar will include a brief demonstration of digital signatures usingTriCipher's MySignatureBook with SAFE-BioPharma credentials. For moreinformation on MySignatureBook and the webinar, please visithttp://www.Tricipher.com.

About TriCipher

TriCipher, Inc. provides a unified authentication infrastructure toprotect web and enterprise portals, the people that use them and the businessprocess that flows through them against fraud and identity theft. TheTriCipher Armored Credential System(TM) (TACS) is the first authenticationsystem that enables companies to deploy and manage multiple types ofcredentials from a single infrastructure. Through this flexible"Authentication Ladder," TriCipher protects customer investment by adjustingauthentication strength to defeat new threats and to meet regulatory changeswithout the need to implement a new infrastructure. Recently, TriCipherintroduced myOneLogin(TM) the first secure on-demand offering that deliversstrong authentication, single sign-on (SSO) convenience and the ability toseamlessly integrate multiple Software as a Service (SaaS) applications in asingle solution. Founded in 2000, TriCipher is headquartered in Los Gatos,Calif. The company is funded by ArrowPath Venture Capital, EPIC Ventures,Intel Capital, RBC Technology Ventures, and Trident Capital. For moreinformation, visit TriCipher on the web at http://www.tricipher.com.

About MySignatureBook

TriCipher MySignatureBook(TM) is a web-based digital signing solution thatgathers multiple signatures from a centrally managed, Web-based workflow to asingle, unaltered document. MySignatureBook ensures end-to-end security forhighly regulated and sensitive documents, and eliminates time-consuming andcostly paper-based signature processes, including shipping and storage.MySignaureBook supports a range of MSB supports a variety of strongcredentials, including TriCipher clientless credentials, SAFE(TM) credentials,TriCipher ID Tool and ID Tool ToGo and any PKCS#11 digital credential. Arobust web services interface makes it easy to integrate MSB with a variety ofapplications and document management systems.

About SAFE-BioPharma Association

SAFE-BioPharma Association is the non-profit association that created andmanages the SAFE-BioPharma(TM) digital identity and signature standard for thepharmaceutical and healthcare industries. The SAFE-BioPharma industry standardis used to mitigate legal, regulatory and other business risk associated withbusiness-to-business and business-to-regulator electronic transactions. Itfacilitates interoperability by providing a secure, enforceable, andregulatory-compliant way to verify identities of parties involved inelectronic transactions. SAFE-BioPharma's vision is to be a catalyst intransforming the biopharmaceutical and healthcare communities to a fullyelectronic business environment by 2012. The Association's members includeAbbott, Amgen, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Johnson &Johnson, , Merck, Pfizer, Procter & Gamble, Roche and Sanofi-Aventis. For moreinformation, visit http://www.safe-biopharma.org.

SAFE-BioPharma(TM) is a trademark of SAFE-BioPharma Association. Any useof this trademark requires approval from SAFE-BioPharma Association.

All product and company names herein may be trademarks of their registeredowners.Participants that attend the Webinar will learn: -- How businesses have saved hundreds of thousands of dollars by no longer needing to handle paper-based signatures -- The benefits of streamlining submissions to FDA and other regulatory agencies -- Strategies for protecting intellectual property and delivering a long term solution to IP preservation -- The 'Green' benefits of digital signatures WHO: Mollie Shields-Uehling, president and CEO, SAFE-BioPharma Association William Barnes, Director of Identity Services, Pfizer Jon Brody, vice president of marketing, TriCipher A managing director of identity services at a leading international systems integrator WHAT: "Cutting Costs with Digital Signatures in the Biopharmaceutical Industry" WHEN: Tuesday, December 16th, 11 a.m. - 12 p.m. PT WHERE: To register please visit: https://www2.gotomeeting.com/register/792964500

SOURCE TriCipher, Inc.
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close